Bulk active ingredients for certain oncologic products are sourced abroad. Some 10 percent of production is exported. Zone procedures would exempt BVL from Customs duty payments on foreign materials used in production for export. The application indicates that the savings from zone procedures will help improve the plant's international competitiveness. In accordance with the Board's regulations, a member of the FTZ Staff has been designated examiner to investigate the application and report to the Board.
Public comment is invited from interested parties.
The closing period for their receipt is August 14, 1995. John J. Da Ponte, Jr., Executive Secretary.